RT Book, Section
A1 Manno, Rebecca L.
A1 Yazdany, Jinoos
A1 Tarrant, Teresa K.
A1 Kwan, Mildred
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193125637
T1 Systemic Sclerosis (Scleroderma)
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193125637
RD 2025/01/16
AB Key  Clinical  Updates  in  Systemic  Sclerosis  (Scleroderma)Tocilizumab,  an  IL-6  inhibitor,  slows  the  rate  of  decline  in  pulmonary  function  and  may  be  used  as  an  alternative  for  patients  who  cannot  tolerate  mycophenolate  mofetil.  Azathioprine  is  an  additional  option  for  treatment  of  systemic  sclerosis–associated  lung  disease.Khanna  D  et  al;  focuSSced  Investigators.  Lancet  Respir  Med.  [PMID:  32866440]